Peptide Decoding
New?New to peptides?Start here →
Decoding

Cerebroprotein Hydrolysate_Dosage, benefits & legal status

Also known as cerebroprotein hydrolysate I, brain protein hydrolysate

Published September 29, 2026

A generic name for pig-brain peptide mixtures, sometimes including Cerebrolysin itself.

Brain recoveryTissue peptide extractClinical use
DoseGiven in hospital as a course of daily infusions
FrequencyHospital courses of daily infusions
RouteInto a vein or muscle (hospital products)
StatusApproved abroad, not FDA approved
CycledHospital courses of daily infusions

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Cerebroprotein Hydrolysate?

Plain language first. The technical label stays, but it never stands alone.

Overview

A pig-brain peptide mixture sold under a generic name. Hospital versions exist in India and China, and the powder vendors sell is a different product of unpublished composition.

The technical version

Cerebroprotein hydrolysate describes enzymatic hydrolysates of lipid-free porcine brain protein, containing low molecular weight peptides and free amino acids. The term covers several distinct preparations from different manufacturers, including injections used in Indian and Chinese hospitals and cerebroprotein hydrolysate I, and in Chinese-language usage it is also applied to Cerebrolysin. Composition varies with tissue, enzymes and process, and no preparation is standardised to a single active molecule.

What it's used for

Given in hospitals in India and China as an add-on for stroke, head injury and dementia. Sold by peptide vendors as a small vial of powder.

02

How does Cerebroprotein Hydrolysate work?

What it does in the body, and where.

Cerebroprotein hydrolysate is made rather than synthesised, which is why it cannot be pinned to one formula.

  1. 01
    Pig brain protein is broken down with enzymes
    Fat is removed and the protein is cut into small peptides and free amino acids. What comes out depends on the tissue, the enzymes and the process, so each maker's product differs.
  2. 02
    The proposed action is neurotrophic
    The idea, shared with Cerebrolysin, is that some fragments act like the growth factors that keep nerve cells alive. Animal studies support parts of this, but no single active molecule has been identified.
  3. 03
    The name is used loosely
    Chinese papers apply it to Cerebrolysin as well as to other brain hydrolysates, and one Chinese meta-analysis translates it as Cerebrolysin in its English abstract. When you read a study, check which product it tested.
  4. 04
    Hospital trials test hospital products
    The human evidence comes from infusions of manufactured medicines of known strength. None of it describes a vendor's research powder.
03

What else is it used for?

Each group carries its own evidence level.

Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

Stroke

Clinical use
  • ReviewA 2017 Chinese meta-analysis pooled 20 randomised trials with 3,313 patients given it on top of standard care for acute ischaemic stroke. Neurological and daily-living scores improved, while death, disability and adverse reactions did not differ.
  • ReviewThe review's English abstract calls the product Cerebrolysin, which shows how loosely the two names are used.

Young children with developmental delay

Early research
  • Human trial102 children under three had rehabilitation, and the treatment group also received 14 days of infusions followed by oral derivatives. At 90 days that group had improved more on fine motor and adaptive skills. Adverse events occurred in 55.3% against 47.7%, and none were serious.

Safety

Clinical use
  • Human observationCase reports describe allergic reactions in patients with traumatic brain injury and a whole-body inflammatory response in a stroke patient after hospital injections.
Often left out

Vendor descriptions often borrow Cerebrolysin's trial record for this product, and some papers really do use the two names for the same thing. That does not make a vendor's vial equivalent to either. The hospital trials tested manufactured medicines of known strength, given as infusions, while a small vial of research powder is a different product whose composition nobody has published.

The published record

Research index

32

Papers and trials about Cerebroprotein Hydrolysate

5 papers tagged human · 4 not reviews or lab · 1 clinical trial publications

Compare this against the whole library →

In animals13
In the lab1
Reviews0
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

Cerebroprotein Hydrolysate vial rendering
Compound field notes

At a glance

Four things to know about Cerebroprotein Hydrolysate

01

Evidence

Clinical use

02

Category

Healing and recovery

03

Common vial

Varies

04

Half-life

Not a single number

04

How much, and do you cycle it?

The range, and whether you take breaks.

Given in hospital as a course of daily infusions, hospital courses of daily infusions. Hospital courses of daily infusionsTrial dose

Human use comes in courses. The Chinese study in young children gave 14 days of daily infusions, then switched to oral derivatives for the rest of 90 days. No course has been studied for a vendor's product.

Source: Hua R, et al. Neuropsychiatr Dis Treat, 2025

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Not a single numberNo figure

A mixture of many fragments rather than one molecule, so a single half-life would not mean much.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: Given in hospital as a course of daily infusionsNo range

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW0 / 100 units
What it costs

Cerebroprotein Hydrolysate starts at $59.00 across 2 vendors.

2 listings, last read Sep 28, 2026. Shipping and card fees are not included.

See all 2 listings →
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Cerebroprotein Hydrolysate keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Allergy to pork or to animal-derived medicines, since it is made from pig brain
  • Epilepsy or a seizure disorder
  • Severe kidney disease
  • Pregnancy

Stop and get help

These are emergencies. Seek care.
  • Rash, swelling of the face or throat, or trouble breathing
  • Fever, chills or a racing heart after a dose
  • A seizure

Common effects

Expected, and usually mild.
  • Dizziness
  • Confusion
  • Reactions where it was injected or infused

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Cerebroprotein Hydrolysate approved?

And where the numbers on this page come from.

Not approved, but legal to obtain. Cerebroprotein Hydrolysate has no FDA approval, and it can be prescribed or prepared by a compounding pharmacy in the United States. It is approved in China and India, but not in the United States.

What has happened recently

Not FDA-approved. Hospital products sold under this name are used in India and China and come from many manufacturers. A vendor's research vial is not one of those products.

Guides for this compound

Sources

Last reviewed 29 September 2026

Beyond these, 32 records are indexed. Browse the records